The FCC has just announced an additional $249M in funding for the COVID-19 Telehealth Program to help healthcare professionals provide connected services to patients in their homes. However, the application window is open only from April 29 to May 6, so it’s important you are immediately aware of the eligible telehealth and connected care services available to your organization, and how to apply.
This new funding is a continuation of the CARES Act which, in April 2020, provided $200 million to provide support to healthcare providers while they responded to the pandemic. Round 1 funds have been depleted, but under Round 2 guidelines, eligible services and devices include:
This program was created to directly benefit Healthcare Providers (HCP) that offer telehealth services, such as, but not limited to:
With such a short filing window, it’s vital to understand your needs for telehealth funding. Perhaps your medical practice was hard hit by a high demand for telemedicine during the height of the pandemic and your office struggled to accommodate calls and scheduling. If you could go back and refit your practice with additional tools, how would they have reduced the stress and demand?
Also ask yourself:
Once approved through the program, healthcare providers pay for services and then must invoice Universal Service Administrative Co. (USAC) for reimbursement. Retroactive funding is available for eligible services and/or devices purchased on or after March 13, 2020 only and includes some services that require monthly recurring charges (such as broadband connectivity or remote patient monitoring services) through September 30, 2021.
UScellular offers several eligible services and devices to help you care for your patients, including:
Our local representatives can provide you resources about the application and appropriation process to help you to take advantage of these new funds, but the filing window is short—April 29-May 6, 2021. To get started today, contact your UScellular business expert at 866-616-5587 or Telehealth.